Tradestie Institutional Equity Comparison Engine
OKYO vs INDP โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
INDP Overall Edge
INDP Captures Institutional Edge (1โ1 Pillars ยท 3โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Indaptus Therapeutics, Inc. Common Stock (INDP) driven by superior Momentum & Technical while OKYO counters with relative strength in Growth & Margin. Fundamentally, OKYO trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus INDP at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OKYO sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against INDP sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
OKYO N/M vs INDP N/M Fwd P/E
Growth & Margin Winner
OKYO
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
INDP
1Y -47.0% vs +36.2% ยท 52W Pos 3% vs 38%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
OKYO
NASDAQ
OKYO Pharma Limited Ordinary Shares
Biological Products, (No Diagnostic Substances)
$1.07
-7.76% 1D
Market Cap
$62.7M
1M Return
-27.21%
1Y Return
-47.03%
Forward P/E
N/M
Unified AI Score
42.8 / 100
HOLD
Tech 38.0
Fund 54.0
Flow 50.0
Mom 45.0
INDP
NASDAQ
Indaptus Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$2.82
-9.9% 1D
Market Cap
$480.8M
1M Return
-5.69%
1Y Return
+36.23%
Forward P/E
N/M
Unified AI Score
49.5 / 100
HOLD
Tech 30.0
Fund 45.0
Flow 50.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OKYO -47.03%
INDP +36.23%
Spread: +83.26 pp (INDP Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OKYO TTM Op. Margin: 0.0%
INDP TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OKYO vs INDP. Trailing 12-month operating profitability (OKYO 0.0% vs INDP 0.0%) and valuation multiples (OKYO N/M vs INDP N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OKYO | INDP | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.7M | $480.8M | Larger Scale | INDP |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -263.8% | -318.0% | Higher ROE | OKYO |
| 52-Week Range Position Momentum | 3% ($1โ$3) | 38% ($1โ$6) | Stronger Trend | INDP |
| Beta / 30D Volatility Risk Regime | 1.00ฮฒ ยท 76% Vol | 1.18ฮฒ ยท 99% Vol | Lower Realized Risk | OKYO |
| Unified Institutional Score Composite Signal | 42.8 / 100 (HOLD) | 49.5 / 100 (HOLD) | Higher Composite | INDP |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OKYO vs INDP Buy Guide
OKYO
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
INDP
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OKYO nor INDP registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.